Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Testicular Neoplasms

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Testicular Neoplasms in 1 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Testicular Neoplasms: Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms.

Research Excerpts

ExcerptRelevanceReference
"For example, a subset of testicular cancer patients still die even though testicular cancer is considered a paradigm of cisplatin-sensitive solid tumors, but the mechanisms of chemoresistance remain elusive."1.36Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer. ( Bischoff, R; de Jong, S; di Pietro, A; Gibcus, JH; Gietema, JA; Koster, R; Suurmeijer, AJ; Timmer-Bosscha, H; van den Berg, A, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koster, R1
di Pietro, A1
Timmer-Bosscha, H1
Gibcus, JH1
van den Berg, A1
Suurmeijer, AJ1
Bischoff, R1
Gietema, JA1
de Jong, S1

Other Studies

1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Testicular Neoplasms

ArticleYear
Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer.
    The Journal of clinical investigation, 2010, Volume: 120, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chromones; Cisplatin; Cyclin-Dependent Kinase 2;

2010